drugset / Trial / NCT03426267
Evaluation of Efficacy and Safety of SDN-037
RandomizedParallel-groupDouble-blindTreatment
Summary
The efficacy and safety of SDN-037 twice daily will be evaluated and compared with vehicle for the treatment of inflammation and pain associated with ocular surgery.
Timeline
- Start
- 2018-09-28
- Primary completion
- 2020-03-05
- Completion
- 2020-03-05
Outcome
Met primary endpoint
release “Clinical Trial of SDN-037 for the Treatment of Inflammation and Pain Associated with Ocular Surgery Met Pre -specified Primary and Secondary Endpoint s” sparc.life ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SDN-037 | Unknown | — | — |
Indications
No indication recorded.